Overview

Phase 1 Bioavailability Study of MELT-100 (Midazolam and Ketamine Sublingual) and IV Midazolam or Ketamine

Status:
Completed
Trial end date:
2020-08-29
Target enrollment:
Participant gender:
Summary
Comparative Bioavailability study testing MELT-100 (midazolam and ketamine sublingual tablet) and IV midazolam or ketamine in healthy volunteers
Phase:
Phase 1
Details
Lead Sponsor:
Melt Pharmaceuticals
Collaborator:
Worldwide Clinical Trials
Treatments:
Ketamine
Midazolam